Enjoying the read? Subscribe for free and stay informed.

Join over 300,000 readers who trust us to stay ahead!

Top 5 VC Deals | AI

Top 5 VC Deals of the Week in AI (11/18/26)

By Christopher Robbins · Nov 19, 2026 Views: 4,677

Top 5 VC Deals of the Week in AI (11/18/26)
Our Top 5 VC Deals of the Week in AI featured funding announcements from Isomorphic Labs, Fractile, Uforce, Genesis AI, and Agile Robots.


This week we continue our series on the top 5 VC-funded deals in AI.

This week our overall AI venture capital activity maintained its momentum from last week, with all five of our listed announcements coming in over $500 million and 17 announcements total coming in over $100 million.

The biggest announcement, per FinSMEs, came from London-based Isomorphic Labs, an AI biotechnology researcher, which raised $5 billion in a Series C to "scale its proprietary drug design engine (IsoDDE), expand deeper into new biology with advanced models, build global infrastructure for AI-led bioengineering, and support translational and clinical development infrastructure as its drug candidates advance to clinical trials," according to its announcement. Our second-place announcement was another London-based AI company, chip developer Fractile, which raised $720 million to "expand operations and its development efforts," according to its announcement. Rounding out the top 5 are announcements from the defense and robotics spaces. All of our top 5 fundraising announcements are from companies founded in or with headquarters in the UK or the EU.

Smaller funding raises that did not quite make our top 5 this week included announcements from the fintech, AI infrastructure, and agentic AI sectors.

Below, we highlight the top five venture capital deals, ranked from the highest to the lowest funding amounts, showcasing the companies at the forefront of the AI revolution...

Top 5 Venture Capital Deals from Nov. 12 - Nov. 18

1. Isomorphic Labs

  • Company Location: London, United Kingdom
  • Description: AI-driven drug discovery company developing artificial intelligence technologies to accelerate pharmaceutical research and the identification and design of new medicines. The company applies advanced computational models to biological and chemical research, seeking to make drug discovery faster, more efficient and less costly.
  • Funding Amount: $5 billion
  • Funding Round: Series C

2. Fractile

  • Company Location: London, United Kingdom
  • Description: AI semiconductor company developing specialized inference chips designed to improve the speed and efficiency of running artificial intelligence models. Its technology targets the growing demand for high-performance, energy-efficient computing infrastructure as AI deployment expands.
  • Funding Amount: $720 million
  • Funding Round: Series C
  • Valuation: $7 billion

3. Uforce

  • Company Location: London, United Kingdom
  • Description: Provider of autonomous defense-technology solutions, developing AI-powered systems designed to support military operations, defense capabilities and national security applications.
  • Funding Amount: $700 million
  • Funding Round: Series A
  • Valuation: $6 billion

4. Genesis AI

  • Company Location: Paris, France, and San Carlos, CA
  • Description: Provider of a robotics platform designed to support the development and deployment of intelligent robotic systems. The company focuses on technologies that enable robots to perform increasingly complex physical tasks through artificial intelligence and automation.
  • Funding Amount: $500 million
  • Funding Round: Series A
  • Valuation: $3.5 billion

5. Agile Robots

  • Company Location: Munich, Germany
  • Description: Developer of AI-controlled humanoid and industrial robots designed to automate manufacturing, assembly and warehouse operations. The company's robotic systems combine artificial intelligence with advanced automation technologies to improve productivity and reduce the need for manual intervention in industrial environments.
  • Funding Amount: $500 million
  • Funding Round: Series F
  • Valuation: $8.5 billion


Written & Researched by DWN Staff
VC Deals Synopsized by ChatGPT Research Source: FinSMEs
Loading suggested stories…